| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/05/2007 | WO2007074491A1 HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS |
| 07/05/2007 | WO2007074475A2 Novel polymorphic forms of ibandronate |
| 07/05/2007 | WO2007074472A2 Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxide |
| 07/05/2007 | WO2007074350A1 Device for the treatment of carotid artery diseases |
| 07/05/2007 | WO2007074347A1 21-deoxymacbecin analogues useful as antitumor agents |
| 07/05/2007 | WO2007074346A2 Modulation of wnt signalling pathways for treating nervous system disorders |
| 07/05/2007 | WO2007074344A1 Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 07/05/2007 | WO2007074341A1 Detection of oesophageal cancer |
| 07/05/2007 | WO2007074340A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
| 07/05/2007 | WO2007074327A1 Hemostatic material |
| 07/05/2007 | WO2007074326A1 Hemostatic material |
| 07/05/2007 | WO2007074291A2 Incontinence treatment methods |
| 07/05/2007 | WO2007074288A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof |
| 07/05/2007 | WO2007074239A1 Testosterone stabilisation in transdermal devices |
| 07/05/2007 | WO2007074176A1 Novel pyrrole derivatives with histone deacetylase inhibitor activity |
| 07/05/2007 | WO2007074171A1 Aza heterocyclics for the treatment of malaria or aids |
| 07/05/2007 | WO2007074170A2 Compositions and methods for the treatment and prevention of disease |
| 07/05/2007 | WO2007074110A1 Oral formulation of anhydrous olanzapine form i |
| 07/05/2007 | WO2007074089A1 Aryl-isoxazol-4-yl-imidazo[1, 5-a]pyridine derivatives |
| 07/05/2007 | WO2007074073A1 Use of alkoxylates of monovalent and polyvalent alcohols or derivatives thereof as an antibiotic substitute in the feeding of animals |
| 07/05/2007 | WO2007074010A1 Process for the production of trans-10, cis 12 octadecadienoic acid |
| 07/05/2007 | WO2007073935A1 Heterocyclic compounds |
| 07/05/2007 | WO2007073934A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | WO2007073921A1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid |
| 07/05/2007 | WO2007073855A1 Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases |
| 07/05/2007 | WO2007073782A1 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 07/05/2007 | WO2007073727A1 Novel compositions against alkyl-acyl-gpc, the derivatives and products thereof |
| 07/05/2007 | WO2007073687A1 A g protein-coupled receptor antagonist and its use for preventing and treating alzheimer’s disease |
| 07/05/2007 | WO2007073682A1 Dropping pill of butylbenzene phthalein and its application |
| 07/05/2007 | WO2007073651A1 4,5-seco abieta diterpene quinones, preparation and use thereof |
| 07/05/2007 | WO2007073646A1 The application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation, chemotherapy sensitization |
| 07/05/2007 | WO2007073583A1 A method of treatment and agents useful for same |
| 07/05/2007 | WO2007058602A3 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 07/05/2007 | WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007056570A3 Levodopa compositions |
| 07/05/2007 | WO2007056393A3 Polycationic viscoelastic compositions |
| 07/05/2007 | WO2007056366A3 Compounds and compositions as ppar modulators |
| 07/05/2007 | WO2007056281A3 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007056184A3 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007053765A3 Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| 07/05/2007 | WO2007050583A3 Aromatic di-acid-containing poly (ester amide) polymers and methods of use |
| 07/05/2007 | WO2007048820A3 Micronised azodicarbonamide, the preparation and use thereof |
| 07/05/2007 | WO2007048042A9 Small molecule inhibitors of hiv-1 capsid assembly |
| 07/05/2007 | WO2007047881A3 Method for treating neuropathic pain |
| 07/05/2007 | WO2007047880A3 Compositions for lowering serum cholesterol and/or triglycerides |
| 07/05/2007 | WO2007047837A3 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders |
| 07/05/2007 | WO2007047698A3 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 07/05/2007 | WO2007047496A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/05/2007 | WO2007047474A3 Biphenyl derivatives as modulators of voltage gated ion channels |
| 07/05/2007 | WO2007044662A3 Separation of fulvestrant isomers |
| 07/05/2007 | WO2007043094A3 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof |
| 07/05/2007 | WO2007042902A3 Extracts from nyctanthes arbortristis for the treatement of leishmaniasis |
| 07/05/2007 | WO2007042554A3 Methods and compositions for treating immune disorders |
| 07/05/2007 | WO2007040565A9 Enhancing treatment of cancer and hif-1 mediated disoders with adenosine a3 receptor antagonists |
| 07/05/2007 | WO2007039869A3 Use of neboglamine in the treatment of toxicodependency |
| 07/05/2007 | WO2007038138A3 Amido compounds and their use as pharmaceuticals |
| 07/05/2007 | WO2007038058A3 Amino-aza-adamantane derivatives and methods of use |
| 07/05/2007 | WO2007036028A9 Compositions for and methods of granzyme b inhibition |
| 07/05/2007 | WO2007027560A3 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 07/05/2007 | WO2007026254A3 Benzodiazepine derivatives , their preparation and the therapeutic use thereof |
| 07/05/2007 | WO2007026071A8 Use of dha in the form of phospholipids for the preparation of a composition that is intended for the treatment of respiratory failure |
| 07/05/2007 | WO2007023495A3 Method for production of single- and multi-layer microcapsules |
| 07/05/2007 | WO2007021603A3 Methods and compositions for soothing oral and nasal tissues |
| 07/05/2007 | WO2007018314A3 Therapeutic agent for diabetes |
| 07/05/2007 | WO2007017894B1 PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE |
| 07/05/2007 | WO2007017764A3 Substituted benzimidazole compounds with dual nos inhibitory activity and muopioid agonist activity |
| 07/05/2007 | WO2007016639A3 M3 muscarinic acetylcholine receptor antagonists |
| 07/05/2007 | WO2007016228A3 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 07/05/2007 | WO2007014940A8 Quinoline derivatives as antibacterical agents |
| 07/05/2007 | WO2007013123A8 Cyclodextrins for blood detoxification |
| 07/05/2007 | WO2007010012A3 Combination of a pyrimidylaminobenzamide and an mtor kinase inhibitor |
| 07/05/2007 | WO2006138503A8 New regimens for oral monophasic contraceptives |
| 07/05/2007 | WO2006135949A3 Tumour treatment with gliotoxin derivatives |
| 07/05/2007 | WO2006135723A3 Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 07/05/2007 | WO2006131790A3 Oral ribavirin pharmaceutical composition |
| 07/05/2007 | WO2006123285A3 Dispersible bosertan tablet |
| 07/05/2007 | WO2006098761A3 Hsp90 inhibitors, methods of making and uses therefor |
| 07/05/2007 | WO2006094143A3 Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
| 07/05/2007 | WO2006086449A3 Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines |
| 07/05/2007 | WO2006080549A3 Method and composition for treating central nervous system disorders |
| 07/05/2007 | WO2006074346A3 RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF |
| 07/05/2007 | WO2006071862A3 Polymorphs of 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate |
| 07/05/2007 | WO2006069080A3 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 07/05/2007 | WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 07/05/2007 | WO2006064517A3 Methods for the purification of 20(s)-camptothecin |
| 07/05/2007 | WO2006064217A8 PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | WO2006056697A8 Substituted thieno[2,3-c]pyrazoles, method for the preparation thereof, compositions containing them and use thereof |
| 07/05/2007 | WO2006055970A3 Enhancing treatment of hif-1 mediated disorders with adenosine a3 receptor agonists |
| 07/05/2007 | WO2006055752A3 INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME |
| 07/05/2007 | WO2006053024A3 Lactam compounds and their use as pharmaceuticals |
| 07/05/2007 | WO2006045963A3 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 07/05/2007 | WO2006044860A3 Thiadiazole compounds and methods of use |
| 07/05/2007 | WO2006044665A3 Neuroprotective spirostenol pharmaceutical compositions |
| 07/05/2007 | WO2006039079A3 Topical endoparasiticide and ectoparasiticide formulations |
| 07/05/2007 | WO2006026496A3 Immunosuppressive ningalin compounds |
| 07/05/2007 | WO2006020768A3 Chemically modified oligonucleotides |
| 07/05/2007 | WO2005120500A3 Sleeves for accommodating a circulation enhancement device |
| 07/05/2007 | WO2005115482A3 Methods for identifying chemical modulators of ras superfamily gtpase activity |